PPH Legal Blog

Now in its second week, the trial for the Fen-phen lawyers continues.  A junior lawyer involved in the settlement, who has testified for four days, says the main lawyers on the case, Cunningham Jr., Gallion, and Mills Jr., never gave the clients a chance to protest the $200 million settlement or the attorney fees.  The […]

[Read more →]

Fen-phen, the diet drug wonder of the 1990’s, created many unfortunate and severe health complications in its users, including heart valve damage and primary pulmonary hypertension (PPH).  PPH is a rare and incurable disease which causes increased blood pressure and oxygen depletion in the lungs, forcing many patients to struggle for breath, especially with increased […]

[Read more →]

The lawyers who sued the makers of Fen-Phen on behalf of thousands of plaintiffs have been awarded $412 million for their efforts that spanned nearly a decade.  Federal Judge Harvey Bartle III of Philadelphia awarded the money for more than 578,000 hours of work.  The money is in addition to a $156 million settlement that […]

[Read more →]

Arena Pharmaceuticals is convinced that they can create a weight-loss drug from the same family of drugs as the notorious fen-phen without causing heart valve damage or primary pulmonary hypertension.
A safety review of the drug which involved a 12 month trial shows no heart valve damage or hypertension in patients who participated in the study. […]

[Read more →]

A 2007 law that requires all clinical studies of new medications, except Phase-1 Safety Studies, is increasing the amount of information available to patients and doctors alike.
This new law is particularly useful because pharmaceutical companies frequently don’t disclose any negative results of their clinical trials. In addition, they don’t publish results that show very little […]

[Read more →]